The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Intravenous (IV) Ibuprofen Market From 2026 To 2030?
The intravenous (iv) ibuprofen market has seen significant expansion in recent years. It is expected to expand from $9.37 billion in 2025 to $10.51 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.1%. This historical growth can be attributed to several factors including a heightened need for postoperative pain management, the prevalent use of NSAIDs within hospital settings, an increase in the volume of surgical procedures, a growing occurrence of acute inflammatory conditions, and the well-established clinical efficacy of ibuprofen for both pain and fever.
The market for intravenous (iv) ibuprofen is projected to experience substantial expansion over the upcoming years. This market is predicted to reach a value of $16.41 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.8%. This anticipated growth during the forecast period is primarily fueled by a rising demand for pain management approaches that reduce opioid use, a wider acceptance of iv therapies within ambulatory surgical centers, an uptick in hospitalization rates for both pediatric and elderly patients, the broadening of acute care facilities, and a stronger inclination towards analgesic treatments that act quickly. Key trends identified for the forecast period encompass a surging uptake of iv ibuprofen for managing pain post-surgery, an expanded application of non-opioid analgesics in acute care environments, a heightened preference for fast-acting injectable pain relief options, a broadened application of iv ibuprofen in pediatric and critical care, and an enhanced availability of highly concentrated iv ibuprofen formulations.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23429&type=smp
Which Factors Are Influencing The Growth Of The Intravenous (IV) Ibuprofen Market?
The increasing occurrence of pain disorders is anticipated to stimulate the expansion of the intravenous ibuprofen market in the future. These conditions involve persistent or long-lasting pain that interferes with daily life, frequently stemming from problems with nerves, muscles, bones, or inflammation. The growing incidence of pain disorders is attributable to an aging demographic, given that elderly individuals are more susceptible to developing chronic ailments such as arthritis, osteoarthritis, and nerve pain, thereby heightening the demand for efficient pain management. Intravenous ibuprofen aids in managing pain through its rapid pain-relieving action, rendering it highly suitable for acute and post-surgical discomfort. It also decreases inflammation and boosts patient well-being, which contributes to more effective treatment outcomes in healthcare environments. As an illustration, in January 2024, data from the Office for Health Improvement and Disparities, a UK-based government department, indicated that the proportion of individuals aged 16 and over reporting a long-term musculoskeletal condition increased to 18.4% in 2023, a rise from 17.6% in 2022. Consequently, the increasing occurrence of pain disorders is fueling the expansion of the intravenous ibuprofen market.
What Are The Different Segment Types In The Intravenous (IV) Ibuprofen Market Segment Breakdown?
The intravenous (iv) ibuprofen market covered in this report is segmented –
1) By Product Type: Conventional Intravenous (IV) Ibuprofen, High-Concentration Intravenous (IV) Ibuprofen
2) By Strength: 100 Milligrams (mg), 200 Milligrams (mg), 400 Milligrams (mg), 800 Milligrams (mg)
3) By Age Group: Pediatrics, Adults
4) By Application: Pain, Fever, Inflammation, Other Applications
5) By End-User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End-Users
Subsegments:
1) By Conventional Intravenous (IV) Ibuprofen: Pediatric Intravenous (IV) Ibuprofen, Adult Intravenous (IV) Ibuprofen
2) By High-Concentration Intravenous (IV) Ibuprofen: Single-Dose Vial, Multi-Dose Vial
Which Trends Are Influencing Demand In The Intravenous (IV) Ibuprofen Market?
Leading companies in the intravenous ibuprofen sector are prioritizing the creation of advanced drug formulations, such as opioid-free analgesics, to improve pain management while reducing opioid dependence. An opioid-free analgesic is a pain-relieving medicine that contains no opioids, thereby eliminating the risk of addiction and opioid-related adverse effects. For example, Hikma Pharmaceuticals plc, a UK-based pharmaceutical firm, introduced COMBOGESIC IV (acetaminophen and ibuprofen) injection in the US in February 2024, following its Food and Drug Administration (FDA) approval in October 2023. This intravenous, non-opioid pain reliever is indicated for mild to moderate pain alleviation and as an auxiliary treatment for moderate to severe pain management. By integrating two active ingredients with differing mechanisms, COMBOGESIC IV offers an innovative, non-opioid pain management solution for healthcare practitioners.
Who Are The Well-Known Companies In The Intravenous (IV) Ibuprofen Market?
Major companies operating in the intravenous (iv) ibuprofen market are Pfizer Inc., Sanofi S.A., Novartis AG, Fresenius SE & Co. KGaA, Teva Pharmaceutical Industries Ltd., Baxter International, Mylan N.V., Sandoz Group AG, Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, Eurolife Healthcare Pvt. Ltd., B. Braun Holding GmbH & Co. KG, AFT Pharmaceuticals Ltd, Cumberland Pharmaceuticals Inc., Delex Pharma International Inc., Xgen Pharmaceuticals Djb Inc., Wellona Pharma, Hyloris Pharmaceuticals SA
Get The Full Intravenous (IV) Ibuprofen Market Report:
https://www.thebusinessresearchcompany.com/report/intravenous-iv-ibuprofen-global-market-report
Which Geographic Region Dominates The Intravenous (IV) Ibuprofen Market?
North America was the largest region in the intravenous (IV) ibuprofen market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) ibuprofen market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Intravenous (IV) Ibuprofen Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/intravenous-iv-ibuprofen-global-market-report
Browse Through More Reports Similar to the Global Intravenous (IV) Ibuprofen Market 2026, By The Business Research Company
Cardiovascular Ultrasound Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-ultrasound-global-market-report
Vascular Imaging Market Report
https://www.thebusinessresearchcompany.com/report/vascular-imaging-global-market-report
Contrast Enhanced Ultrasound Market Report
https://www.thebusinessresearchcompany.com/report/contrast-enhanced-ultrasound-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model